GLP-1 Insurance Coverage Checker

See what your plan may cover, and what to do next.

By GLP Index editorial Updated August 9, 2026

Coverage outlook

Your next steps

    Coverage is decided by your specific plan, not by the drug. This is a general read to point you in the right direction. The real answer is on your plan's formulary or one call to member services away.

    Coverage is about your plan, not the drug

    Whether a GLP-1 is covered comes down to two things: what it’s prescribed for, and what your specific plan chose to include. The checker above walks through both and gives you a realistic outlook plus concrete next steps, because “does insurance cover Ozempic?” has no single answer, only a per-plan one.

    The single biggest fork is the reason for the prescription:

    • For type 2 diabetes, GLP-1s (Ozempic, Mounjaro, Rybelsus, Trulicity, Victoza) are covered by most commercial plans, Medicare Part D, and Medicaid, usually after a prior authorization.
    • For weight loss, coverage is much less reliable. This is where plans diverge sharply, and where most of the frustration lives.

    Why weight-loss coverage is a coin flip

    When a GLP-1 is prescribed purely for weight management (Wegovy, Zepbound, Saxenda), coverage depends on decisions your plan sponsor made:

    • Commercial / employer plans may or may not include an “anti-obesity medication” benefit. Some employers buy it; many carve it out to control costs. This one fact, whether it is in your formulary, determines almost everything, which is why it’s worth one phone call to confirm.
    • Medicare Part D has historically excluded weight-loss-only drugs. Coverage is expanding when the drug is prescribed for an approved related condition (like cardiovascular risk), but pure weight-loss use often still isn’t covered.
    • Medicaid is decided state by state. Some cover weight-loss GLP-1s with prior authorization, many don’t.

    The quirk people notice most: a plan can cover Ozempic (a diabetes drug) while denying Wegovy (the same molecule, approved for weight loss). The medicine is nearly identical; the indication is what your plan is reacting to.

    If you’re denied

    A denial is a starting point, not a dead end:

    1. Prior authorization. Ask your prescriber to submit one documenting your BMI, any weight-related conditions, and prior weight-loss attempts. This clears many first-pass denials.
    2. Appeal. If the PA is denied, appeal, because a meaningful share of approvals happen on the second attempt with better documentation.
    3. Check for a covered indication. If you have a qualifying condition (type 2 diabetes, established heart disease), a different, covered indication may apply.
    4. Go cash-smart. If your plan flatly excludes weight-loss drugs, manufacturer savings cards, cash-pay pharmacy programs, and telehealth flat pricing are the realistic routes. Our cheapest-GLP-1 guide lays out the options.

    Confirming the real answer

    This tool points you in the right direction, but the definitive answer is on your plan’s formulary or one call to member services away. Ask specifically: “Are anti-obesity medications a covered benefit on my plan, and is [drug name] on the formulary?” Have your member ID ready, and note the tier and copay if it is covered. This is general guidance, not a coverage determination or medical advice.

    FAQ

    Common questions

    Does insurance cover GLP-1s for weight loss?

    It depends heavily on your plan. When a GLP-1 is prescribed for type 2 diabetes, most plans cover it. When it's for weight loss, coverage is far less certain. Many commercial plans exclude anti-obesity drugs, Medicare Part D cannot cover weight-loss use at all by statute, though a separate $50-a-month program has run since July 2026, and Medicaid varies by state. The checker gives a read based on your specifics.

    Why does my plan cover Ozempic but not Wegovy?

    They're the same drug (semaglutide) but approved for different things, Ozempic for diabetes and Wegovy for weight loss. Plans that cover diabetes drugs but exclude weight-loss drugs will cover one and not the other, even though they're chemically nearly identical. That's about the indication, not the medicine.

    What can I do if my GLP-1 is denied?

    A denial isn't the end. Ask your prescriber to submit a prior authorization (or an appeal if one was already denied) documenting your BMI, any related conditions, and prior attempts, since many approvals come on the second try. If your plan flatly excludes weight-loss drugs, look at manufacturer savings cards, cash-pay pharmacy programs, and telehealth flat pricing instead.

    Does Medicare cover Wegovy or Zepbound?

    Not through Part D, which by statute cannot cover a drug used for weight loss. That bar has not changed. What changed is that since 1 July 2026 CMS has run a separate, time-limited program called the Medicare GLP-1 Bridge, giving eligible beneficiaries Wegovy, Zepbound KwikPen or Foundayo for a flat $50 a month, scheduled through 31 December 2027. Its criteria are stricter than most write-ups suggest, and any GLP-1 already paid for by a Medicare drug plan this year rules you out. If a GLP-1 is prescribed for an approved non-weight indication such as type 2 diabetes or cardiovascular risk reduction, that routes to Part D as normal.

    Sources

    What this is based on

    1. Medicare GLP-1 Bridge: Information for Providers and Prior Authorization Criteria (Centers for Medicare & Medicaid Services)
    2. Medicare and GLP-1 Coverage: Part D and Anti-Obesity Medications (KFF (Kaiser Family Foundation))
    3. Coverage of Obesity Treatment in State Medicaid Programs (KFF (Kaiser Family Foundation))

    This tool is for general education only and is not medical advice. Results are estimates based on the numbers you enter and published clinical averages; individual results vary. Talk to a licensed healthcare provider about your own situation. Medical disclaimer

    Find the right GLP‑1 in 2 minutes

    Free · No account · Independent